Intech Investment Management LLC boosted its holdings in shares of Silicon Laboratories, Inc. (NASDAQ:SLAB - Free Report) by 12.7% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 20,225 shares of the semiconductor company's stock after acquiring an additional 2,273 shares during the quarter. Intech Investment Management LLC owned approximately 0.06% of Silicon Laboratories worth $2,277,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in SLAB. GAMMA Investing LLC increased its position in Silicon Laboratories by 99.6% during the first quarter. GAMMA Investing LLC now owns 1,126 shares of the semiconductor company's stock worth $127,000 after acquiring an additional 562 shares during the period. Principal Financial Group Inc. boosted its stake in shares of Silicon Laboratories by 72.2% in the 1st quarter. Principal Financial Group Inc. now owns 129,911 shares of the semiconductor company's stock valued at $14,624,000 after purchasing an additional 54,463 shares in the last quarter. KBC Group NV lifted its position in Silicon Laboratories by 27.1% during the 1st quarter. KBC Group NV now owns 1,625 shares of the semiconductor company's stock worth $183,000 after buying an additional 346 shares in the last quarter. Oppenheimer Asset Management Inc. lifted its position in Silicon Laboratories by 2.9% during the 1st quarter. Oppenheimer Asset Management Inc. now owns 7,379 shares of the semiconductor company's stock worth $831,000 after buying an additional 210 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC lifted its position in Silicon Laboratories by 9.7% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 2,334 shares of the semiconductor company's stock valued at $290,000 after purchasing an additional 206 shares during the period.
Analyst Upgrades and Downgrades
SLAB has been the subject of a number of research reports. Susquehanna increased their target price on Silicon Laboratories from $110.00 to $150.00 and gave the stock a "neutral" rating in a research note on Tuesday, July 22nd. Benchmark reissued a "buy" rating and set a $160.00 price target on shares of Silicon Laboratories in a research note on Tuesday, May 27th. Morgan Stanley dropped their price target on Silicon Laboratories from $157.00 to $144.00 and set an "equal weight" rating on the stock in a research note on Wednesday, August 6th. Barclays increased their price objective on Silicon Laboratories from $100.00 to $130.00 and gave the stock an "equal weight" rating in a report on Tuesday, August 5th. Finally, KeyCorp upped their target price on Silicon Laboratories from $160.00 to $180.00 and gave the stock an "overweight" rating in a research note on Tuesday, July 8th. Five analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $151.13.
Get Our Latest Research Report on Silicon Laboratories
Silicon Laboratories Stock Up 0.6%
Shares of NASDAQ:SLAB opened at $134.53 on Tuesday. The business's 50 day moving average is $135.66 and its 200 day moving average is $126.20. The stock has a market cap of $4.41 billion, a P/E ratio of -41.78 and a beta of 1.52. Silicon Laboratories, Inc. has a 52-week low of $82.82 and a 52-week high of $160.00.
Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last posted its earnings results on Tuesday, August 5th. The semiconductor company reported $0.11 earnings per share for the quarter, topping analysts' consensus estimates of $0.09 by $0.02. The company had revenue of $192.85 million during the quarter, compared to analyst estimates of $192.57 million. Silicon Laboratories had a negative return on equity of 7.21% and a negative net margin of 14.88%.Silicon Laboratories's revenue was up 32.6% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.56) earnings per share. Silicon Laboratories has set its Q3 2025 guidance at 0.200-0.400 EPS. On average, sell-side analysts anticipate that Silicon Laboratories, Inc. will post -0.97 EPS for the current fiscal year.
Insiders Place Their Bets
In other Silicon Laboratories news, SVP Brandon Tolany sold 8,000 shares of the firm's stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $145.23, for a total value of $1,161,840.00. Following the transaction, the senior vice president directly owned 62,328 shares of the company's stock, valued at $9,051,895.44. This trade represents a 11.38% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Over the last 90 days, insiders have sold 12,070 shares of company stock valued at $1,703,472. Company insiders own 1.60% of the company's stock.
About Silicon Laboratories
(
Free Report)
Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Silicon Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Silicon Laboratories wasn't on the list.
While Silicon Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report